You are here

Novo Nordisk

On a quest to challenge Novo Nordisk in obesity, transpacific startup picks up $70M — and a pair of seasoned execs

On a quest to challenge Novo Nordisk in obesity, transpacific startup picks up $70M — and a pair of seasoned execs

Endpoints

Sciwind Biosciences

Flag link:

Novo Nordisk settles insulin pricing suit for $100M

Novo Nordisk settles insulin pricing suit for $100M

Endpoints

Flag link:

HHS lines up Novartis, Lilly, AstraZeneca and 3 other drugmakers for fines due to drug discount violations

HHS lines up Novartis, Lilly, AstraZeneca and 3 other drugmakers for fines due to drug discount violations

Endpoints

United Therapeutics

Flag link:

Novo Nordisk, Roche see outsized threats from U.S. drug pricing talks: analysts

Novo Nordisk, Roche see outsized threats from U.S. drug pricing talks: analysts

Fierce Pharma

Flag link:

House committee questions Eli Lilly, Sanofi and Novo Nordisk as insulin prices remain 'unacceptably high'

House committee questions Eli Lilly, Sanofi and Novo Nordisk as insulin prices remain 'unacceptably high'

Endpoints

Flag link:

Demand for Novo Nordisk's new weight-loss drug Wegovy outstripped early supply, analysts say

Demand for Novo Nordisk's new weight-loss drug Wegovy outstripped early supply, analysts say

Fierce Pharma

Flag link:

Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs

Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs

Fierce Pharma

Express Scripts

Flag link:

Novo Nordisk puts $1.2B on the table for Prothena’s ATTR drug, teeing up Alnylam challenge and cardiovascular expansion

Novo Nordisk puts $1.2B on the table for Prothena’s ATTR drug, teeing up Alnylam challenge and cardiovascular expansion

Fierce Biotech

ATTR amyloidosis

Flag link:

Obesity Drug's Promise Now Hinges On Insurance Coverage

Obesity Drug's Promise Now Hinges On Insurance Coverage

NPR

Flag link:

ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom

ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom

Fierce Pharma

type 2 diabetes

Flag link:

Lumen and Novo Nordisk link up on oral biologics for cardiometabolic disease

Lumen and Novo Nordisk link up on oral biologics for cardiometabolic disease

Pharma Letter

Lumen Bioscience

Flag link:

Former Emisphere investors sue over 'ill-timed' $1.8B sale to Novo Nordisk

Former Emisphere investors sue over 'ill-timed' $1.8B sale to Novo Nordisk

Fierce Pharma

Flag link:

Fresh off $598M deal with Novo Nordisk, a Japanese stem cell company is on its way to the clinic with a different approach to treating heart failure

Fresh off $598M deal with Novo Nordisk, a Japanese stem cell company is on its way to the clinic with a different approach to treating heart failure

Endpoints

Flag link:

Novo Nordisk, armed with Wegovy green light, preps aggressive push to build obesity market

Novo Nordisk, armed with Wegovy green light, preps aggressive push to build obesity market

Fierce Pharma

Flag link:

Novo Nordisk's semaglutide set to tackle obesity with hotly-anticipated FDA green light

Novo Nordisk's semaglutide set to tackle obesity with hotly-anticipated FDA green light

Fierce Pharma

Flag link:

2nd time's the charm? Novo Nordisk reups bid for high-dose Ozempic after March FDA snub

2nd time's the charm? Novo Nordisk reups bid for high-dose Ozempic after March FDA snub

Fierce Pharma

Flag link:

Go or no go? Aducanumab’s day of reckoning

Go or no go? Aducanumab’s day of reckoning

EP Vantage

Ascendis Pharma

Flag link:

Novo Nordisk continues pushing beyond diabetes, netting PhII win for former Corvidia kidney program

Novo Nordisk continues pushing beyond diabetes, netting PhII win for former Corvidia kidney program

Endpoints

chronic kidney disease

clinical trials

Flag link:

Recall report: Novo Nordisk recalls samples of multiple insulin products after storage screw-up

Recall report: Novo Nordisk recalls samples of multiple insulin products after storage screw-up

Endpoints

product recalls

Flag link:

Pages